单基因狼:追踪单基因突变的治疗影响
Xiuzhi Jia1, Li Tan1, Sixiu Chen1
1Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China; NHC Key Laboratory of Clinical Nephrology (Sun Yat-Sen University) and Guangdong Provincial Key Laboratory of Nephrology, Guangzhou 510080, China.
Clinical immunology (Orlando, Fla.)
|July 22, 2023
概括
单一性狼是一种罕见的系统性红斑狼 (SLE) 形式,由单个基因突变引起严重的免疫系统功能障碍. 这篇评论详细介绍了这种疾病的遗传原因,受影响的免疫路径和新兴治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
- 类风湿病学 类风湿病学
背景情况:
- 单一性狼是一种严重的SLE变体,具有早期发病和家族聚类.
- 超过30种遗传变异与SLE和狼类表型的单基因病因有关.
- 基因突变严重破坏免疫路径,特别是天生的免疫力.
研究的目的:
- 为了提供一个全面的概述单基因突变在单基因狼.
- 阐明由免疫失调驱动的致病机制.
- 讨论对单一性狼的近期治疗进展.
主要方法:
- 关于单一性狼的科学文献的综述.
- 分析遗传变异及其对免疫路径的影响.
- 综合有关致病机制和治疗方法的当前知识.
主要成果:
- 单基因突变会导致补充系统的缺陷,损害核酸和免疫复合物的降解.
- 功能失调的先天免疫导致亲炎性微环境和细胞因子激增.
- 适应性免疫的缺陷导致自身反应性T细胞,过度活化的B细胞和自身免疫抗体.
- 系统性表现包括脏,皮肤和中枢神经系统的表型.
结论:
- 单一性狼的发病过程涉及遗传缺陷和免疫失调之间的复杂相互作用.
- 了解这些机制对于开发有针对性的疗法至关重要.
- 最近的治疗干预措施对管理单一性狼有希望.
更多相关视频
相关概念视频
Lethal Alleles
15.6K
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
15.6K
Pleiotropy
40.6K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.6K
Translation
142.4K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
142.4K
Non-LTR Retrotransposons
11.6K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.6K
Mutations
83.7K
Overview
83.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


